Technical Analysis for PHAS - PhaseBio Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade D 12.14 -0.49% -0.06
PHAS closed down 8.34 percent on Wednesday, June 19, 2019, on 60 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A Down Up
See historical PHAS trend table...

Date Alert Name Type % Chg
Fell Below 50 DMA Bearish -0.49%
Expansion Pivot Sell Setup Bearish Swing Setup -0.49%
Upper Bollinger Band Walk Strength -0.49%
Upper Bollinger Band Touch Strength -0.49%
MACD Bullish Centerline Cross Bullish -8.79%
Pocket Pivot Bullish Swing Setup -8.79%
Upper Bollinger Band Walk Strength -8.79%
Above Upper BB Strength -8.79%
Gapped Up Strength -8.79%
Upper Bollinger Band Touch Strength -8.79%

Older signals for PHAS ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
PhaseBio Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapies to treat orphan diseases with an initial focus on cardiopulmonary indications. Its lead product candidate, PB2452, is a reversal agent for the antiplatelet drug ticagrelor that has completed a Phase 1 clinical trial and is been developed for the treatment of patients on ticagrelor who are experiencing a major bleeding event or those who require urgent surgery. It is also developing PB1046, a fusion protein currently in a Phase 2b clinical trial for the treatment of pulmonary arterial hypertension. The company was founded in 2002 and is based in Malvern, Pennsylvania.
Biopharmaceutical Surgery Chemical Compounds Organic Compounds Pulmonary Arterial Hypertension Pulmonary Hypertension Orphan Diseases
Is PHAS a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 16.65
52 Week Low 2.55
Average Volume 430,792
200-Day Moving Average 0.0
50-Day Moving Average 12.314
20-Day Moving Average 11.215
10-Day Moving Average 11.531
Average True Range 1.0475
ADX 20.64
+DI 29.0183
-DI 14.4505
Chandelier Exit (Long, 3 ATRs ) 10.9375
Chandelier Exit (Short, 3 ATRs ) 12.682499999999999
Upper Bollinger Band 12.7558
Lower Bollinger Band 9.6742
Percent B (%b) 0.82
BandWidth 27.477486
MACD Line 0.1639
MACD Signal Line -0.0663
MACD Histogram 0.2302
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 14.71
Resistance 3 (R3) 14.97 14.39 14.29
Resistance 2 (R2) 14.39 13.76 14.26 14.15
Resistance 1 (R1) 13.30 13.36 13.01 13.04 14.01
Pivot Point 12.72 12.72 12.58 12.59 12.72
Support 1 (S1) 11.63 12.09 11.34 11.37 10.39
Support 2 (S2) 11.05 11.69 10.92 10.25
Support 3 (S3) 9.96 11.05 10.11
Support 4 (S4) 9.70